- Home
- CYD vs BHVN Comparison
CYD vs BHVN Comparison
Compare CYD & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYD
- BHVN
- Stock Information
- Founded
- CYD 1951
- BHVN 2013
- Country
- CYD Singapore
- BHVN United States
- Employees
- CYD N/A
- BHVN N/A
- Industry
- CYD Industrial Machinery/Components
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- CYD Industrials
- BHVN Health Care
- Exchange
- CYD Nasdaq
- BHVN Nasdaq
- Market Cap
- CYD 1.5B
- BHVN 1.7B
- IPO Year
- CYD 1994
- BHVN 2017
- Fundamental
- Price
- CYD $39.45
- BHVN $15.63
- Analyst Decision
- CYD
- BHVN Strong Buy
- Analyst Count
- CYD 0
- BHVN 14
- Target Price
- CYD N/A
- BHVN $49.23
- AVG Volume (30 Days)
- CYD 297.6K
- BHVN 2.4M
- Earning Date
- CYD 08-08-2025
- BHVN 11-11-2025
- Dividend Yield
- CYD 1.33%
- BHVN N/A
- EPS Growth
- CYD 40.10
- BHVN N/A
- EPS
- CYD 1.66
- BHVN N/A
- Revenue
- CYD $3,159,401,156.00
- BHVN N/A
- Revenue This Year
- CYD $42.20
- BHVN N/A
- Revenue Next Year
- CYD $5.06
- BHVN $2,195.07
- P/E Ratio
- CYD $23.92
- BHVN N/A
- Revenue Growth
- CYD 17.99
- BHVN N/A
- 52 Week Low
- CYD $8.61
- BHVN $12.79
- 52 Week High
- CYD $42.60
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- CYD 57.48
- BHVN 51.87
- Support Level
- CYD $38.55
- BHVN $14.32
- Resistance Level
- CYD $40.98
- BHVN $16.24
- Average True Range (ATR)
- CYD 1.71
- BHVN 0.82
- MACD
- CYD -0.56
- BHVN 0.11
- Stochastic Oscillator
- CYD 30.96
- BHVN 60.92
About CYD China Yuchai International Limited
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.